Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinay Varadan

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
JAMA Network Open|April 20, 2019
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast CancerNathaniel Braman, Prateek Prasanna, Jon Whitney, et al.
Cancer Cell|March 16, 2016
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 InhibitorsShom Goel, Qi Wang, April C Watt, et al.
Gastroenterology|February 16, 2019
Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal CancerAndrew E Blum, Srividya Venkitachalam, Durgadevi Ravillah, et al.
Cancer Research|August 10, 2016
RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal AdenocarcinomasAndrew E Blum, Srividya Venkitachalam, Yan Guo, et al.
Elife|May 14, 2020
Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencingTimour Baslan, Jude Kendall, Konstantin Volyanskyy, et al.
Nature Communications|August 12, 2021
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancerRokana Taftaf, Xia Liu, Salendra Singh, et al.
Molecular Oncology|December 21, 2010
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variablesSitharthan Kamalakaran, Vinay Varadan, Hege E Giercksky Russnes, et al.
Nature Communications|July 3, 2019
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesisHarvey W Smith, Alison Hirukawa, Virginie Sanguin-Gendreau, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
JAMA Network Open|April 20, 2019
Association of Peritumoral Radiomics With Tumor Biology and Pathologic Response to Preoperative Targeted Therapy for HER2 (ERBB2)-Positive Breast CancerNathaniel Braman, Prateek Prasanna, Jon Whitney, et al.
Cancer Cell|March 16, 2016
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 InhibitorsShom Goel, Qi Wang, April C Watt, et al.
Gastroenterology|February 16, 2019
Systems Biology Analyses Show Hyperactivation of Transforming Growth Factor-β and JNK Signaling Pathways in Esophageal CancerAndrew E Blum, Srividya Venkitachalam, Durgadevi Ravillah, et al.
Cancer Research|August 10, 2016
RNA Sequencing Identifies Transcriptionally Viable Gene Fusions in Esophageal AdenocarcinomasAndrew E Blum, Srividya Venkitachalam, Yan Guo, et al.
Elife|May 14, 2020
Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencingTimour Baslan, Jude Kendall, Konstantin Volyanskyy, et al.
Nature Communications|August 12, 2021
ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancerRokana Taftaf, Xia Liu, Salendra Singh, et al.
Molecular Oncology|December 21, 2010
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variablesSitharthan Kamalakaran, Vinay Varadan, Hege E Giercksky Russnes, et al.
Nature Communications|July 3, 2019
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesisHarvey W Smith, Alison Hirukawa, Virginie Sanguin-Gendreau, et al.
Pageof 5